| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.045 | 0.4 |